Read + Share
Tan DSW, Kim SW, Ponce Aix S, Sequist LV, et al. Nazartinib for treatment-naive EGFR-mutant non-small cell lung cancer: Results of
a phase 2, single-arm, open-label study. Eur J Cancer 2022;172:276-286.
PMID: 35810553
|
 |
|
Tan DSW, Kim SW, Ponce Aix S, Sequist LV, et al. Nazartinib for treatment-naive EGFR-mutant non-small cell lung cancer: Results of
a phase 2, single-arm, open-label study. Eur J Cancer 2022;172:276-286.
PMID: 35810553
|
|
|
|